Geode Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $57.6M | Buy |
|
|||||
|
2023
Q3 | $38.4M | Buy |
|
|||||
|
2023
Q2 | $27.6M | Buy |
|
|||||
|
2023
Q1 | $27.3M | Buy |
|
|||||
|
2022
Q4 | $32M | Buy |
|
|||||
|
2022
Q3 | $45.8M | Buy |
|
|||||
|
2022
Q2 | $43.4M | Buy |
|
|||||
|
2022
Q1 | $52.5M | Buy |
|
|||||
|
2021
Q4 | $90.4M | Buy |
|
|||||
|
2021
Q3 | $99.2M | Sell |
|
|||||
|
2021
Q2 | $91.9M | Sell |
|
|||||
|
2021
Q1 | $129M | Buy |
|
|||||
|
2020
Q4 | $153M | Buy |
|
|||||
|
2020
Q3 | $95.5M | Buy |
|
|||||
|
2020
Q2 | $65.2M | Buy |
|
|||||
|
2020
Q1 | $39.1M | Buy |
|
|||||
|
2019
Q4 | $56.9M | Buy |
|
|||||
|
2019
Q3 | $33.5M | Buy |
|
|||||
|
2019
Q2 | $42.5M | Buy |
|
|||||
|
2019
Q1 | $27.2M | Buy |
|
|||||
|
2018
Q4 | $13.3M | Buy |
|
|||||
|
2018
Q3 | $13.6M | Buy |
|
|||||
|
2018
Q2 | $13.4M | Buy |
|
|||||
|
2018
Q1 | $5.66M | Hold |
|
|||||
|
2017
Q4 | $3.37M | Buy |
|
|||||
|
2017
Q3 | $1.99M | Buy |
|
|||||
|
2017
Q2 | $372K | Sell |
|
|||||
|
2017
Q1 | $618K | Buy |
|
|||||
|
2016
Q4 | $518K | Buy |
|
|||||
|
2016
Q3 | $706K | Sell |
|
|||||
|
2016
Q2 | $599K | Buy |
|
|||||
|
2016
Q1 | $2.19K | Sell |
|
|||||
|
2015
Q4 | $3.31M | Buy |
|
|||||
|
2015
Q3 | $3.22M | Buy |
|
|||||
|
2015
Q2 | $419K | Buy |
|
|||||
|
2015
Q1 | $349K | Buy |
|